glp-1 active capsule Companion Health Pack Daily Packets GLP-ONE + Receptor Activator
Description
- Oral semaglutide (only FDA approved for diabetes treatment) and injectable liraglutide, (FDA approved for obesity treatment as Saxenda,) lead to relatively modest amount of weight loss
Somda D., Kpordze S
We follow guidelines from the FDA and Endocrine Society, which recommend that GLP-1 agonists be used alongside healthy eating, increased physical activity, and behavioral changes for the best results
Similarly, the comparison of Wegovy and Zepbound places a spotlight on their use primarily for weight management, differing again in their composition and possibly side effect profiles
Dahln A
